- A research initiative of Centre for Global Health Research
- Study Place: BIRDEM
- Study design: Cross-sectional
- Study duration: 8 months
- Number of participants: 1023
- Status: Complete
- Funding: CGHR, BADAS and University of Oslo
- Key points:
- At the time of recruitment, 80.7% study participants were diagnosed with Non-Proliferative Diabetic Retinopathy (NPDR) and rest 18.3% were diagnosed with Proliferative Diabetic Retinopathy (PDR).
- Only 6.5% study participants were diagnosed with Non-Proliferative Diabetic Retinopathy (NPDR) and 2.4% were diagnosed with Proliferative Diabetic Retinopathy (PDR).